apo-alendronate/vitamin d3 tablet
apotex inc - alendronic acid (alendronate sodium); vitamin d3 (cholecalciferol) - tablet - 70mg; 2800unit - alendronic acid (alendronate sodium) 70mg; vitamin d3 (cholecalciferol) 2800unit - vitamin d
apo-alendronate/vitamin d3 tablet
apotex inc - alendronic acid (alendronate sodium); vitamin d3 (cholecalciferol) - tablet - 70mg; 5600unit - alendronic acid (alendronate sodium) 70mg; vitamin d3 (cholecalciferol) 5600unit - vitamin d
dronalen plus d-cal alendronic acid 70mg/colecalciferol 140 microgram tablet and 1250mg calcium carbonate tablet composite pack
merck sharp & dohme (australia) pty ltd - alendronate sodium,calcium carbonate,colecalciferol -
fosamax plus d-cal alendronic acid 70mg/colecalciferol 140 microgram tablet and 1250mg calcium carbonate tablet composite pack
merck sharp & dohme (australia) pty ltd - alendronate sodium,calcium carbonate,colecalciferol -
dronalen plus 70 mg/140 microgram alendronic acid 70 mg (as alendronate sodium) and colecalciferol 140 micrograms tablet blister
merck sharp & dohme (australia) pty ltd - alendronate sodium,colecalciferol -
fosamax once weekly alendronic acid 70mg (as sodium) tablet blister pack (new dosage regimen 16/4/03)
merck sharp & dohme (australia) pty ltd - alendronate sodium -
fosamax alendronic acid 10mg (as sodium) tablet blister pack (new dosage regimen 16/4/03)
merck sharp & dohme (australia) pty ltd - alendronate sodium -
alendronate plus d3 70 mg/140 ug apotex alendronate (as sodium) 70 mg and colecalciferol 140 microgram (5600 iu) tablet blister
dr reddys laboratories australia pty ltd - colecalciferol, quantity: 0.14 mg; alendronate sodium, quantity: 91.37 mg (equivalent: alendronic acid, qty 70 mg) - tablet, uncoated - excipient ingredients: magnesium stearate; povidone; sucrose; butylated hydroxytoluene; croscarmellose sodium; microcrystalline cellulose; gelatin; medium chain triglycerides; colloidal anhydrous silica - alendronate plus d3 70 mg/140 microgram apotex are indicated for the treatment of: osteoporosis in select patients where vitamin d supplementation is recommended, prior to treatment, osteoporosis must be confirmed by: - the finding of low bone mass of at least 2 standard deviations below the gender specific mean for young adults or by - the presence of osteoporotic fracture
alendronate plus d3 70 mg/70 ug apotex alendronate (as sodium) 70 mg and colecalciferol 70 microgram (2800 iu) tablet blister pa
dr reddys laboratories australia pty ltd - alendronate sodium, quantity: 91.37 mg (equivalent: alendronic acid, qty 70 mg); colecalciferol, quantity: 0.07 mg - tablet, uncoated - excipient ingredients: gelatin; povidone; croscarmellose sodium; colloidal anhydrous silica; microcrystalline cellulose; medium chain triglycerides; butylated hydroxytoluene; magnesium stearate; sucrose - alendronate plus d3 70 mg/70 microgram apotex are indicated for the treatment of: osteoporosis in select patients where vitamin d supplementation is recommended, prior to treatment, osteoporosis must be confirmed by: - the finding of low bone mass of at least 2 standard deviations below the gender specific mean for young adults or by - the presence of osteoporotic fracture
fosamax plus 70mg/5600i.u. combination tablet
merck sharp & dohme (malaysia) sdn bhd - alendronate sodium; vitamin d3 100,000 i.u./g, ph. eur. -